AG Mednet has announced the availability of new capabilities to enable sponsors, CROs and core laboratories to take delivery of electronic trial data into configurable file structures residing either locally or in any of their network shares. This functionality provides higher-quality data and less delays,...

To make trials more efficient and ensure compliance, syneed medidata GmbH, an independent CRO in Germany, has signed a Master Services Agreement with Boston’s AG Mednet....

Improved quality-control measures in clinical trials are gaining traction. AG Mednet driven by its mission of quality at the source for image-intensive trials helps sponsors and core labs comply with the FDA’s newly stated guidance. ...

AG Mednet’s Submission Quality & Compliance software was recently named a finalist for the Massachusetts Technology Leadership Council’s 2013 Innovative Technology of the Year for Healthcare/Life Sciences. The award was announced before a crowd of more than 200 tech executives at the Microsoft NERD Center...

On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a changing clinical trial research landscape. Among the clinical trial...

AG Mednet today announced a new core lab partnership with the Methodist DeBakey Heart & Vascular Center (MDHVC) echocardiography core laboratory at The Methodist Hospital in Houston. By selecting AG Mednet quality assurance and compliance software, MDHVC is strengthening its commitment to quality in multi-center...

Founder, President and CEO of AG Mednet, honored as one of 20 innovators changing the face of the clinical trial industry by The CenterWatch Monthly The CenterWatch Monthly – one of the nation’s leading pharmaceutical and clinical trial industry publications – has selected Boston’s Abraham Gutman...

Executing its mission to bring zero-delay imaging technology to clinical trials around the world, AG Mednet today announced the signing of a Master Services Agreement with Biovisiq, a Japanese imaging core laboratory (ICL). As the adoption of Asia and Japan-specific clinical trials continues to grow,...

Unnecessary procedures and amendments to clinical trial protocols cost sponsors more than $5 billion per year and are responsible for 20% of clinical trial budgets, according to recent research. To help reduce these costs and create zero-delay clinical trials, AG Mednet, Inc. has licensed from...

AG Mednet, Inc. today announced that it has signed an OEM agreement with ICON Medical Imaging, a division of ICON plc, further embedding AG Mednet’s quality control, compliance, de-identification and image transfer technology into ICON’s imaging trial offerings. AG Mednet provides the quality assurance and...